focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAOR.L Regulatory News (AOR)

  • There is currently no data for AOR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

5 May 2009 09:18

RNS Number : 6675R
Aortech International PLC
05 May 2009
 



TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES

 

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):

AorTech International plc

2. Reason for the notification (please state Yes/No): ( )

An acquisition or disposal of voting rights: ( Yes )

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( )

An event changing the breakdown of voting rights: ( )

Other (please specify)( )

3. Full name of person(s) subject to the notification obligation (iii):

The Goldman Sachs Group, Inc.

4. Full name of shareholder(s) (if different from 3.) (iv):

Goldman Sachs International

  Goldman Sachs Bank AG

 

5. Date of the transaction (and date on which the threshold is crossed or reached if different) (v):

  21 April 2009

6. Date on which issuer notified:

23 April 2009

7. Threshold(s) that is/are crossed or reached:

7%

 

8. Notified details:

A: Voting rights attached to shares

Class/type of shares if possible using the ISIN CODE

Situation previous to the Triggering transaction (vi)

Number of shares

Number of voting Rights (viii)

GB0033360586

445,987

9.23%

Resulting situation after the triggering transaction (vii)

Class/type of shares if possible using the ISIN CODE

Number of shares

Number of voting rights (ix)

% of voting rights

Direct (x)

Indirect (xi)

Direct

Indirect

GB0033360586

310,594

18,000

6.43%

0.37%

B: Financial Instruments

Resulting situation after the triggering transaction (xii)

Type of financial instrument

Expiration Date (xiii)

Exercise/Conversion Period/Date (xiv)

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

N/A

N/A

N/A

N/A

N/A

Total (A+B)

Number of voting rights

% of voting rights

328,594

6.80%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv):

The interest in 310,594 shares arose from a beneficial interest held by Goldman Sachs International, a wholly-owned indirect subsidiary of GS Inc. These shares are, or will be, registered at CREST in account CREPTEMP.

The interest in 18,000 shares arose from the interest held by Goldman Sachs Bank AG, an ultimately owned subsidiary of GS Inc acting as discretionary manager. We believe that some of these shares are, or will be, registered in the name of Goldman Sachs Securities (Nominees), Limited. 

 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

General email contact:

shareholderdisclosures@gs.com

14. Contact name:

Shannon Sutherland 

15. Contact number:

0207 774 6249

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUUUMGAUPBURA
Date   Source Headline
17th Feb 20115:06 pmRNSHolding(s) in Company
17th Jan 20117:00 amRNSAorTech Enters Orthopaedic Market
20th Dec 20107:00 amRNSAorTech Announces Interim Results
13th Dec 20107:00 amRNSAortech Announces Human Use of Header Technology
27th Sep 20103:00 pmRNSResult of AGM
9th Sep 20104:49 pmRNSDirector/PDMR Shareholding
24th Aug 20107:00 amRNSAnnual Report and Accounts
2nd Aug 20107:00 amRNSAorTech Announces Year End Preliminary Results
28th Jul 20108:56 amRNSHolding(s) in Company
24th May 20107:00 amRNSAorTech Signs Licensing Agreement
19th May 20107:00 amRNSDirector/PDMR Shareholding
27th Apr 20108:00 amRNSHolding(s) in Company
12th Mar 20104:50 pmRNSDirector/PDMR Shareholding
3rd Dec 20097:00 amRNSAorTech Announces Interim Results
24th Nov 20097:00 amRNSAorTech Receives Record Polymer Order
29th Sep 20097:00 amRNSAnnual Reports and Accounts Posted to Shareholders
21st Sep 20095:06 pmRNSHolding(s) in Company
16th Sep 20095:19 pmRNSResult of AGM
16th Sep 20097:00 amRNSAorTech Signs Licensing Agreement with SynCardia
16th Sep 20097:00 amRNSAorTech AGM Statement
27th Jul 20097:00 amRNSAorTech Issued US Patent for Polymer Heart Valve
22nd Jul 20097:00 amRNSAorTech Announces Final Results
9th Jul 20095:57 pmRNSHolding in Company - correction
19th Jun 200910:53 amRNSHolding(s) in Company
17th Jun 200912:07 pmRNSHolding(s) in Company
15th Jun 20095:13 pmRNSHolding(s) in Company
15th Jun 20095:11 pmRNSHolding(s) in Company
10th Jun 20097:00 amRNSAorTech Signs Licensing Agreement
5th Jun 200912:38 pmRNSHolding(s) in Company
18th May 20097:00 amRNSAorTech Signs Licensing Agreement
5th May 20099:18 amRNSHolding(s) in Company
6th Apr 20097:00 amRNSAorTech International Director/PDMR Shareholding
29th Jan 20097:00 amRNSAorTech Expands Agreement with St. Jude Medical
17th Dec 20087:00 amRNSAorTech Announces Half Yearly Results
8th Dec 20087:00 amRNSAorTech Signs New Licensing Agreement
25th Nov 20087:00 amRNSFDA Approval Granted to Key AorTech Customer
30th Sep 200810:47 amRNSHolding(s) in Company
19th Sep 200810:24 amRNSAnnual Report and Accounts
12th Sep 200812:53 pmRNSHolding(s) in Company
8th Sep 20082:22 pmRNSHolding(s) in Company
27th Aug 20082:50 pmRNSResult of AGM
27th Aug 20087:00 amRNSAGM Statement
26th Aug 200810:00 amRNSAgreement
21st Aug 20087:00 amRNSAorTech Issued Patent for Bio
6th Aug 20087:00 amRNSHolding(s) in Company
4th Aug 20087:00 amRNSAorTech Issued Patent for Pol
28th Jul 20087:00 amRNSSuccess in Animal Trials
23rd Jul 20087:00 amRNS1st Human Use of Cardiac Cann
17th Jun 20087:00 amRNSFinal Results
17th Apr 20085:39 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.